Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1997 1
2006 1
2007 2
2008 3
2009 2
2010 2
2011 2
2012 1
2014 2
2015 2
2016 1
2017 2
2019 3
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA.
Hosono Y, Niknafs YS, Prensner JR, Iyer MK, Dhanasekaran SM, Mehra R, Pitchiaya S, Tien J, Escara-Wilke J, Poliakov A, Chu SC, Saleh S, Sankar K, Su F, Guo S, Qiao Y, Freier SM, Bui HH, Cao X, Malik R, Johnson TM, Beer DG, Feng FY, Zhou W, Chinnaiyan AM. Hosono Y, et al. Among authors: escara wilke j. Cell. 2017 Dec 14;171(7):1559-1572.e20. doi: 10.1016/j.cell.2017.11.040. Cell. 2017. PMID: 29245011 Free PMC article.
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.
Asangani IA, Dommeti VL, Wang X, Malik R, Cieslik M, Yang R, Escara-Wilke J, Wilder-Romans K, Dhanireddy S, Engelke C, Iyer MK, Jing X, Wu YM, Cao X, Qin ZS, Wang S, Feng FY, Chinnaiyan AM. Asangani IA, et al. Among authors: escara wilke j. Nature. 2014 Jun 12;510(7504):278-82. doi: 10.1038/nature13229. Epub 2014 Apr 23. Nature. 2014. PMID: 24759320 Free PMC article.
Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer.
Smith DC, Daignault-Newton S, Grivas P, Reichert ZR, Hussain M, Cooney KA, Caram M, Alva A, Jacobson J, Yablon C, Mehra R, Escara-Wilke J, Shelley G, Keller ET. Smith DC, et al. Among authors: escara wilke j. Clin Genitourin Cancer. 2020 Aug;18(4):332-339.e2. doi: 10.1016/j.clgc.2019.10.019. Epub 2020 Mar 7. Clin Genitourin Cancer. 2020. PMID: 32299729 Clinical Trial.
Raf kinase inhibitor protein (RKIP) in cancer.
Escara-Wilke J, Yeung K, Keller ET. Escara-Wilke J, et al. Cancer Metastasis Rev. 2012 Dec;31(3-4):615-20. doi: 10.1007/s10555-012-9365-9. Cancer Metastasis Rev. 2012. PMID: 22684368 Review.
Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance.
Zhang M, Osisami M, Dai J, Keller JM, Escara-Wilke J, Mizokami A, Keller ET. Zhang M, et al. Among authors: escara wilke j. Mol Cancer Res. 2017 Apr;15(4):457-466. doi: 10.1158/1541-7786.MCR-16-0392. Epub 2017 Jan 13. Mol Cancer Res. 2017. PMID: 28087740 Free PMC article.
New trends in the treatment of bone metastasis.
Keller ET, Dai J, Escara-Wilke J, Hall CL, Ignatoski K, Taichman RS, Keller J. Keller ET, et al. Among authors: escara wilke j. J Cell Biochem. 2007 Dec 1;102(5):1095-102. doi: 10.1002/jcb.21540. J Cell Biochem. 2007. PMID: 17955492 Free article. Review.
Targeting the MLL complex in castration-resistant prostate cancer.
Malik R, Khan AP, Asangani IA, Cieślik M, Prensner JR, Wang X, Iyer MK, Jiang X, Borkin D, Escara-Wilke J, Stender R, Wu YM, Niknafs YS, Jing X, Qiao Y, Palanisamy N, Kunju LP, Krishnamurthy PM, Yocum AK, Mellacheruvu D, Nesvizhskii AI, Cao X, Dhanasekaran SM, Feng FY, Grembecka J, Cierpicki T, Chinnaiyan AM. Malik R, et al. Among authors: escara wilke j. Nat Med. 2015 Apr;21(4):344-52. doi: 10.1038/nm.3830. Epub 2015 Mar 30. Nat Med. 2015. PMID: 25822367 Free PMC article.
25 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page